2-oxindole has been researched along with Alloxan Diabetes in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Anikina, LV; Babkov, DA; Bezsonova, EN; Borisov, AV; Efremov, AM; Lozinskaya, NA; Perfilova, VN; Proskurnina, MV; Spasov, AA; Tsymlyakov, MD; Tyurenkov, IN; Zakharyascheva, OY; Zaryanova, EV | 1 |
1 other study(ies) available for 2-oxindole and Alloxan Diabetes
Article | Year |
---|---|
Synthesis and biological evaluation of 3-substituted 2-oxindole derivatives as new glycogen synthase kinase 3β inhibitors.
Topics: A549 Cells; Animals; Binding Sites; Catalytic Domain; Cell Survival; Diabetes Mellitus, Experimental; Glucose Tolerance Test; Glycogen Synthase Kinase 3 beta; Humans; Inhibitory Concentration 50; Molecular Docking Simulation; Oxindoles; Protein Kinase Inhibitors; Rats; Structure-Activity Relationship | 2019 |